Literature DB >> 16287009

Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy.

Jill Griffiths1, Winnie Sia, A M James Shapiro, Ivanna Tataryn, A Robert Turner.   

Abstract

BACKGROUND: Immune thrombocytopenic purpura (ITP) is a condition with potential hazard during pregnancy for both mother and fetus if platelet concentrations fall below a critical level. This report describes the use of laparoscopic splenectomy following unsuccessful medical management. CASE: A 35-year-old primigravid woman with systemic lupus erythematosis (SLE) developed ITP several years before becoming pregnant. She was treated early in pregnancy with high-dose oral prednisone and weekly intravenous immunoglobulin (IVIG) alternating with anti-D immune globulin, but laparoscopic splenectomy was indicated at 20 weeks' gestation because of thrombocytopenia. Following surgery, she continued prednisone and intermittent IVIG therapy until spontaneous delivery at 34 weeks' gestation. A small accessory spleen was identified postpartum by nuclear medicine scan. Satisfactory platelet concentrations were maintained postpartum using danazol and prednisone.
CONCLUSION: Laparoscopic splenectomy is a therapeutic option for women with ITP during pregnancy that fails to respond to medical management.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16287009     DOI: 10.1016/s1701-2163(16)30729-0

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  12 in total

1.  Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy: this statement was reviewed and approved by the Board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), September 2007. It was prepared by the SAGES Guidelines Committee.

Authors:  Hori Yumi
Journal:  Surg Endosc       Date:  2008-02-21       Impact factor: 4.584

Review 2.  Hematologic complications of pregnancy.

Authors:  Danielle M Townsley
Journal:  Semin Hematol       Date:  2013-07       Impact factor: 3.851

Review 3.  Diagnosis and laparoscopic treatment of surgical diseases during pregnancy: an evidence-based review.

Authors:  Heidi Jackson; Steven Granger; Raymond Price; Michael Rollins; David Earle; William Richardson; Robert Fanelli
Journal:  Surg Endosc       Date:  2008-06-14       Impact factor: 4.584

4.  Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy.

Authors:  Jonathan Pearl; Raymond Price; William Richardson; Robert Fanelli
Journal:  Surg Endosc       Date:  2011-09-23       Impact factor: 4.584

5.  Successful obstetric and hematologic outcome of aplastic anemia in a pregnant Jehovah's Witness.

Authors:  Grzegorz Jakiel; Michał Ciebiera; Aneta Słabuszewska-Jóźwiak; Bartosz Horosz; Małgorzata Bińkowska; Maria Wilińska; Małgorzata Malec-Milewska
Journal:  Int J Immunopathol Pharmacol       Date:  2016-07-05       Impact factor: 3.219

6.  SAGES guidelines for the use of laparoscopy during pregnancy.

Authors:  Jonathan P Pearl; Raymond R Price; Allison E Tonkin; William S Richardson; Dimitrios Stefanidis
Journal:  Surg Endosc       Date:  2017-06-22       Impact factor: 4.584

7.  Efficacy and safety of laparoscopic splenectomy in thrombocytopenia secondary to systemic lupus erythematosus.

Authors:  Jin Zhou; Zhong Wu; Zongguang Zhou; Zhiqiang Wang; Yi Liu; Xiang-Yang Huang; Bing Peng
Journal:  Clin Rheumatol       Date:  2013-04-03       Impact factor: 2.980

Review 8.  Immune thrombocytopenia in pregnancy.

Authors:  Evi Stavrou; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2009-12       Impact factor: 3.722

9.  Splenectomy during pregnancy: treatment of refractory immune thrombocytopenic purpura.

Authors:  Reeta Mahey; Simran Deep Kaur; Sunil Chumber; Alka Kriplani; Neerja Bhatla
Journal:  BMJ Case Rep       Date:  2013-12-20

10.  Moderate to Severe Thrombocytopenia During Pregnancy: A Single Institutional Experience.

Authors:  Bum Jun Kim; Hyeong Su Kim; Jung Han Kim; Keun Young Lee
Journal:  Indian J Hematol Blood Transfus       Date:  2017-02-21       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.